受强制性开放获取政策约束的文章 - Hinda Najem了解详情
可在其他位置公开访问的文章：19 篇
A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma
J Groot, M Ott, J Wei, C Kassab, D Fang, H Najem, B O’Brien, ...
CNS oncology 11 (2), CNS87, 2022
强制性开放获取政策： US National Institutes of Health, Cancer Prevention Research Institute of …
Intratumoral delivery of STING agonist results in clinical responses in canine glioblastoma
CE Boudreau, H Najem, M Ott, C Horbinski, D Fang, CM DeRay, ...
Clinical Cancer Research 27 (20), 5528-5535, 2021
强制性开放获取政策： US National Institutes of Health
New approaches to glioblastoma
M Khasraw, Y Fujita, C Lee-Chang, IV Balyasnikova, H Najem, ...
Annual review of medicine 73 (1), 279-292, 2022
强制性开放获取政策： US National Institutes of Health
Macrophage–endothelial cell crosstalk orchestrates neutrophil recruitment in inflamed mucosa
X Ren, LD Manzanares, EB Piccolo, JM Urbanczyk, DP Sullivan, ...
The Journal of Clinical Investigation 133 (15), 2023
强制性开放获取政策： US National Institutes of Health
The eclectic nature of glioma-infiltrating macrophages and microglia
VA Arrieta, H Najem, E Petrosyan, C Lee-Chang, P Chen, AM Sonabend, ...
International journal of molecular sciences 22 (24), 13382, 2021
强制性开放获取政策： US National Institutes of Health
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression
H Najem, M Ott, C Kassab, A Rao, G Rao, A Marisetty, AM Sonabend, ...
JCI insight 7 (9), 2022
强制性开放获取政策： US National Institutes of Health
cGAS-STING pathway targeted therapies and their applications in the treatment of high-grade glioma
S Tripathi, H Najem, AS Mahajan, P Zhang, JT Low, AH Stegh, MA Curran, ...
F1000Research 11, 2022
强制性开放获取政策： US National Institutes of Health
Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas
MW Youngblood, Z Erson-Omay, C Li, H Najem, S Coșkun, E Tyrtova, ...
Nature communications 14 (1), 6279, 2023
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute
The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma
M Sooreshjani, S Tripathi, C Dussold, H Najem, J de Groot, RV Lukas, ...
Cancers 15 (14), 3739, 2023
强制性开放获取政策： US National Institutes of Health
Clinical management of supratentorial non-skull base meningiomas
A Adekanmbi, MW Youngblood, CL Karras, EA Oyetunji, J Kalapurakal, ...
Cancers 14 (23), 5887, 2022
强制性开放获取政策： US National Institutes of Health
Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution
CH Lucas, K Mirchia, K Seo, H Najem, W Chen, N Zakimi, A Choudhury, ...
Research Square, 2023
强制性开放获取政策： US National Institutes of Health
CD11c+ CD163+ Cells and signal transducer and activator of transcription 3 (STAT3) expression are common in melanoma leptomeningeal disease
H Najem, A Marisetty, C Horbinski, J Long, JT Huse, IC Glitza Oliva, ...
Frontiers in immunology 12, 745893, 2021
强制性开放获取政策： US National Institutes of Health
Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review
S Budhiraja, H Najem, S Tripathi, NR Wadhawani, C Horbinski, M McCord, ...
Cancers 15 (14), 3655, 2023
强制性开放获取政策： US National Institutes of Health
NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy
A Choudhury, MA Cady, CHG Lucas, H Najem, JJ Phillips, B Palikuqi, ...
bioRxiv, 2023
强制性开放获取政策： US National Institutes of Health
Myeloid cell classification and therapeutic opportunities within the glioblastoma tumor microenvironment in the single cell-omics era
CJ Larkin, VA Arrieta, H Najem, G Li, P Zhang, J Miska, P Chen, ...
Frontiers in immunology 13, 907605, 2022
强制性开放获取政策： US National Institutes of Health
Antigen-presenting B cells promote TCF-1+ PD1- stem-like CD8+ T-cell proliferation in glioblastoma
D Hou, H Wan, JL Katz, S Wang, BA Castro, GI Vazquez-Cervantes, ...
Frontiers in immunology 14, 1295218, 2024
强制性开放获取政策： US National Institutes of Health, American Brain Tumor Association
A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin
J Liang, D Fang, J Gumin, H Najem, M Sooreshjani, R Song, A Sabbagh, ...
Cancers 15 (4), 1085, 2023
强制性开放获取政策： US National Institutes of Health
Prohibitin Expression in Antigen-Presenting Cells: Implications for Inciting Trigger in CNS IgG4-Related Disease
H Najem, VA Arrieta, J Duffy, S Tripathi, M Zannikou, S Dhiantravan, ...
Annals of case reports 9 (1), 2024
强制性开放获取政策： US National Institutes of Health
peer review: awaiting peer review
S Tripathi, H Najem, AS Mahajan, P Zhang, JT Low, AH Stegh, MA Curran, ...
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定